InvestorsHub Logo
Followers 7
Posts 1173
Boards Moderated 0
Alias Born 11/13/2018

Re: Bouf post# 236555

Saturday, 12/21/2019 6:51:16 PM

Saturday, December 21, 2019 6:51:16 PM

Post# of 423976
Buyouts are at a premium because the premise is that a large pharma can promote the drug better than a small pharma. If there is no buyout premium that means that Amarin is doing a great job. I'm okay with it either way. Since reduce-it results have come out Amarin has had a big presence at every conference and have been in every publication. Dr Bhatt has been a great spokesman for the drug and I don't think there could have been anyone better. Standard of Care should make this easy to sell whether they do it alone or with a buyout.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News